Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 23,926 shares at $14.18 ($339K) on 2017-12-15, disclosed to the SEC on 2017-12-19.
Open-market sale of $339k STML by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.18 | 11,943 | $169K | 49.9% |
| 2 | $14.18 | 11,943 | $169K | 49.9% |
| 3 | $14.75 | 40 | $590 | 0.2% |
| Total | $14.18 avg | 23,926 | $339K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |